Carolyn Wu - research works

Sixteen (8.8%) required early retreatment at a median postmenstrual age (PMA) of 40.4 weeks (IQR, 38.44-43.3).

There were differences in the proportion of early retreated infants (21.5% for laser vs 1.7% for injection, P < .001).

The median PMA at late retreatment was 45.6 weeks (IQR, 43.7-47.4).

Similarly, patients in the bevacizumab group had lower odds of requiring early retreatment compared to those with laser (OR, 0.08; 95% CI, 0.04-0.18).

The primary laser group was older at first treatment (median postmenstrual age, 39.1 weeks vs 36.1 and 35.7 weeks for early- and late-deferred laser groups [P < 0.01]).

Zone 1 disease was more common in anti-VEGF groups (43%-45% vs 1.9% [P < 0.01]).

Retinal detachment rates were not significantly different (3.1% primary laser vs 0.0% in anti-VEGF groups [P = 0.31] when excluding 2 eyes of 1 patient with numerous missed examinations and an atypical follow-up schedule due to medical instability in the early deferred laser group).

Specifically, 22.4% of mothers and 28.1% of fathers were diagnosed with strabismus, and 27.7% of mothers and 32.0% of fathers had conditions associated with strabismus (subnormal stereopsis, phorias 10 prism diopters (PD) or more, or a history of patching and exercises).

There were no significant differences in rates of abnormal parental examination results based on strabismus type of the child.

Most parents shared the same deviation type with their children, signifying familial phenotypic inheritance.

Stereopsis was subnormal in 14.9% of controls.